Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Nagy Zoltan | 0001428109 | Mar-24-2011 | director, officer: President, CEO & CFO |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Lotus Bio-Technology Development Corp.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
D | Document | Acc-no: 0001213900-22-082534 (33 Act) Size: 7 KB | Dec-23-2022 | 221484692 |
15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001213900-21-031682 (34 Act) Size: 10 KB |
Jun-09-2021 | 211005356 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-21-020688 (34 Act) Size: 186 KB |
Apr-07-2021 | 21813087 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-21-011136 (34 Act) Size: 208 KB |
Feb-23-2021 | 21666489 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-21-004504 (34 Act) Size: 161 KB |
Jan-27-2021 | 21556653 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-21-003397 (34 Act) Size: 331 KB |
Jan-21-2021 | 21541417 |
8-K | Document | Current report filing Acc-no: 0001079974-19-000490 (34 Act) Size: 16 KB |
Sep-20-2019 | 191105321 |
8-K | Document | Current report filing Acc-no: 0001511164-19-000052 (34 Act) Size: 14 KB |
Apr-10-2019 | 19741316 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001511164-18-000410 (34 Act) Size: 30 KB |
Jun-29-2018 | 18927567 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001511164-18-000078 (34 Act) Size: 238 KB |
Feb-13-2018 | 18599235 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001511164-17-000663 (34 Act) Size: 245 KB |
Nov-13-2017 | 171195829 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001511164-17-000557 (34 Act) Size: 240 KB |
Sep-13-2017 | 171082568 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001511164-17-000537 (34 Act) Size: 239 KB |
Aug-21-2017 | 171042891 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001511164-17-000497 (34 Act) Size: 31 KB |
Aug-14-2017 | 171027910 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001511164-17-000395 (34 Act) Size: 467 KB |
Jul-14-2017 | 17964683 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001511164-17-000369 (34 Act) Size: 31 KB |
Jun-29-2017 | 17937230 |
8-K | Document | Current report filing Acc-no: 0001511164-17-000352 (34 Act) Size: 16 KB |
Jun-19-2017 | 17918279 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001511164-17-000251 (34 Act) Size: 242 KB |
May-08-2017 | 17821043 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001511164-17-000076 (34 Act) Size: 32 KB |
Feb-14-2017 | 17606471 |
8-K | Document | Current report filing Acc-no: 0001511164-17-000068 (34 Act) Size: 16 KB |
Feb-10-2017 | 17592359 |
Recent 20 filings. View all Lotus Bio-Technology Development Corp. filings
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by